A controlled trial of transcutaneous vagus nerve stimulation for the treatment of pharmacoresistant epilepsy
Aihua L, Lu S, Liping L, Xiuru W, Hua L, Yuping W
Epilepsy & behavior : E&B · 2014
Key finding
Auricular taVNS produced significantly greater seizure-frequency reduction and quality-of-life improvement than control stimulation in pharmacoresistant epilepsy.
- Condition
- Epilepsy
- Stimulation
- taVNS
- Evidence tier
- Controlled Clinical Trial
- Participants
- 60
Cite this study
Aihua, L., Lu, S., Liping, L., Xiuru, W., Hua, L., & Yuping, W. (2014). A controlled trial of transcutaneous vagus nerve stimulation for the treatment of pharmacoresistant epilepsy. Epilepsy & behavior : E&B.
Related studies in Epilepsy
Can transcutaneous auricular vagus nerve stimulation be considered a viable adjuntive therapy in drug-resistant epilepsy? A systematic review and meta-analysis of randomized controlled trials
Moro et al. · Epilepsy & behavior : E&B · 2025 · Systematic Review / Meta-Analysis
The effect of Vagus nerve stimulation (VNS) on seizure control, cognitive function, and quality of life in individuals with drug-resistant epilepsy: A systematic review article
Melese et al. · Epilepsia open · 2024 · Systematic Review / Meta-Analysis
Effects of vagus nerve stimulation on cognitive function in patients with epilepsy: a systematic review and meta-analysis
Kong et al. · Frontiers in neurology · 2024 · Systematic Review / Meta-Analysis
Transcutaneous auricular vagus nerve stimulation for epilepsy
Zhang et al. · Seizure · 2024 · Systematic Review / Meta-Analysis
Summary by Vagus Research. Always consult the primary source for the authoritative record.